VelcadeSpend on cancer per patient in England 2006 - 2007
£9,334
Compare this with other PCTs: highest amount spent was £17,028, lowest was £5,182, and average PCT spend per cancer patient was £8,437.
Exceptional funding for cancer treatment
The following information was requested from the PCT under the Freedom of Information Act.
Written protocols
Bristol PCT has an Exceptional Funding protocol. It covers all exceptional requests and is not just specifically for cancer treatments.
Cancer treatments funded by PCT following exceptional requests
Since 01 October 2006, the PCT has approved 12 requests. Treatments approved were:
- Temozolomide (in line with NICE appraisal)
- Velcade
- Dasatinib
Cancer treatments not funded by PCT following exceptional requests
Since 01 October 2006, the PCT has refused 25 requests. Treatments not funded were:
- Velcade
- Dasatinib
- Bortezomid
- Depocyte Intrathecal Chemotherapy
- Lenalidomide
- Pemetrexate
- Rituximab
- Sutent